Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-01-06 @ 6:02 AM
Study NCT ID:
NCT02227251
Status:
RECRUITING
Last Update Posted:
2025-10-01
First Post:
2014-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Sponsor:
Karyopharm Therapeutics Inc